Speaking at the Jefferies 2012 Global Healthcare Conference in New York, Questcor...

|By:, SA News Editor

Speaking at the Jefferies 2012 Global Healthcare Conference in New York, Questcor Pharmaceuticals' (QCOR +7.5%) says its only product, Acthar, remains strong, and the company is poised for solid Q2 sales numbers. Scripts figures for the drug are up on a M/M basis for treating patients with both multiple sclerosis and nephrotic syndrome. (presentation)